Evidence map›Paper›PMID 21613538›Full record

ArticleMolecular biology of the cell2011

Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity.

Eitan E Zahavi, Joshua A Lieberman, Michael S Donnenberg, Mor Nitzan, Kobi Baruch, Ilan Rosenshine, Jerrold R Turner, Naomi Melamed-Book, Naomi Feinstein, Efrat Zlotkin-Rivkin and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Type IV pili ofEcoSal Plus · 2024
    Review
  5. ThemSphere · 2024
    Article
  6. Article
  7. The Diversity ofMicroorganisms · 2023
    Review
  8. Mutating bothFrontiers in microbiology · 2023
    Article
  9. Landmark Discoveries and Recent Advances in Type IV Pilus Research.Microbiology and molecular biology reviews : MMBR · 2022
    Review
  10. Pathophysiology of enteropathogenicJournal of veterinary science · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Editorial.FEMS microbiology reviews · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Eitan E ZahaviDepartment of Cell and Developmental Biology, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Joshua A Lieberman
Michael S Donnenberg
Mor Nitzan
Kobi Baruch
Ilan Rosenshine
Jerrold R Turner
Naomi Melamed-Book
Naomi Feinstein
Efrat Zlotkin-Rivkin
Benjamin Aroeti
Hebrew University of Jerusalem · ILUniversity of Maryland, Baltimore · USUniversity of Chicago · US

Funding

TRAINING PROGRAM IN INTEGRATIVE MEMBRANE BIOLOGYT32GM008181 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI RIZZO, MEGAN A, TRUDEAU, MATTHEW C · 1987 to 2022
$4.9M
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLIR01AI037606 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DONNENBERG, MICHAEL S · 1995 to 2009
$2.5M
NIAID NIH HHS R01 AI037606NIGMS NIH HHS T32 GM008181
6 · The paper itself

Abstract

Enteropathogenic Escherichia coli (EPEC) is an important human pathogen that causes acute infantile diarrhea. The type IV bundle-forming pili (BFP) of typical EPEC strains are dynamic fibrillar organelles that can extend out and retract into the bacterium. The bfpF gene encodes for BfpF, a protein that promotes pili retraction. The BFP are involved in bacterial autoaggregation and in mediating the initial adherence of the bacterium with its host cell. Importantly, BFP retraction is implicated in virulence in experimental human infection. How pili retraction contributes to EPEC pathogenesis at the cellular level remains largely obscure, however. In this study, an effort has been made to address this question using engineered EPEC strains with induced BFP retraction capacity. We show that the retraction is important for tight-junction disruption and, to a lesser extent, actin-rich pedestal formation by promoting efficient translocation of bacterial protein effectors into the host cells. A model is proposed whereby BFP retraction permits closer apposition between the bacterial and the host cell surfaces, thus enabling timely and effective introduction of bacterial effectors into the host cell via the type III secretion apparatus. Our studies hence suggest novel insights into the involvement of pili retraction in EPEC pathogenesis.

Indexed as

AnimalsArabinoseCaco-2 CellsCell LineDiarrhea, InfantileDogsEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFimbriae, BacterialHeLa CellsHumansInfant, NewbornPhosphorylationTyrosineArabinoseBfpF protein, E coliEscherichia coli ProteinsTyrosine

Identifiers

PMID21613538
PMCPMC3135470
OpenAlexW2138982333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.